Angel News

Angel News

Back to Homepage

19th October 2017

Maven Capital Partners has exited its investment in Crawford Scientific, a leading supplier of chromatography products and analytical services to the laboratory research and testing sectors, following its sale to Limerston Capital Partners I, LP. The sale realised a return for Maven clients of 4.7x the initial investment in just over three years, with an IRR of 70%. 


Register now to read full story

In order to read the full story we need you to register with us, please click the link below:

Register Now

Add a comment:




Enter the characters in the image shown:

Back to Homepage